Kramer Levin Closes $368.9 Million Life Sciences/Healthcare Company Loan Securitization
Kramer Levin represented the issuer in connection with a $368,930,000 securitization of senior secured loans made to life sciences and healthcare services companies.
We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.